Stability indicating RP‐HPLC method for determination of dimethyl fumarate in presence of its main degradation products: Application to degradation kinetics
Authors:
- 30 November 2020
- journal article
- research article
- Published by Wiley in Journal of Separation Science
- Vol. 44 (3) , 726-734
Abstract
A stability‐indicating reverse phase‐high‐perfromance liquid chromatography method for the quantitative determination of dimethyl fumarate in presence of its main degradation products was developed. The chromatographic conditions were optimized using two‐level full factorial design, chromatographic analysis was performed using Inertsil® column (250 × 4.6 mm, 5 μm) maintained at 25°C. Mobile phase was a mixture of water (pH 2.6 adjusted with phosphoric acid) and methanol (40:60, v/v) at a flow rate 1.0 mL/min, detection was performed at 210 nm using diode array detector. Stress degradation of dimethyl fumarate under acidic, alkaline, neutral, oxidative, photolytic, and thermal conditions was carried out, it was found to be very susceptible to hydrolysis under acidic and alkaline conditions; further investigation of degradation kinetics over pH range 1–9 was carried out. The degradation rate constant (K), t1/2 and t90 were calculated. Dimethyl fumarate show decreasing in stability in the following pH order: 7 < 5 < 3 < 1 < 9. The method was validated as per ICH guidelines, the method was found to be linear over concentration range 10–150 μg/mL with coefficient of determination (r2) 0.9997. The method was successfully applied for dimethyl fumarate determination in Marclerosis® dosage form within run time less than eight minutes without interference from excipients.Keywords
This publication has 17 references indexed in Scilit:
- A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasisExperimental Dermatology, 2018
- Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studiesMultiple Sclerosis Journal, 2017
- Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A reviewJournal of Chromatography B, 2016
- Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusionJournal of Neuroinflammation, 2015
- Characterization of process-related impurities including forced degradation products of alogliptin benzoate and the development of the corresponding reversed-phase high-performance liquid chromatography methodJournal of Separation Science, 2014
- Dimethyl Fumarate (Tecfidera)Annals of Pharmacotherapy, 2013
- Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC methodJournal of Pharmaceutical Analysis, 2012
- Effects of dimethyl fumarate on neuroprotection and immunomodulationJournal of Neuroinflammation, 2012
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathwayBrain, 2011
- The Immunopathology of Multiple Sclerosis: An OverviewBrain Pathology, 2007